GATA-1 Is a central transcription-activator of erythroid differentiation. In the present work we have studied the kinetics of Its expression and activity during development of normal human erythroid progenitors, grown in primary cultures. In response to the addition of erythropoietin (Epo), the cells undergo proliferation and differentiation in a synchronized fashion. This recently developed experimental system allows biochemical dissection of erythroid differentiation in a physiological meaningful environment. No DNA-blnding activity of GATA-1 could be detected before the addition of Epo, although a very low level of mRNA was observed. Following Epo addition there was a sharp parallel rise in both mRNA and DNA-blnding activity, consistent with positive autoregulation of the GATA-1 gene. After reaching a peak on day 7-9, both mRNA and protein activity decreased. The binding activity of the ubiquitous factor SP1 showed a biphasic pattern; Its second peak usually coincided with the GATA-1 peak, suggesting that SP1 also plays a specific role in erythroid maturation. The highest activity of GATA-1 per erythroid cell was found on day 6-8, immediately preceding the major rise In globin gene mRNA and in the number of hemoglobinlzed cells. The results Imply that a high level of GATA-1 activity Is necessary for globin gene expression and erythroid maturation, suggesting that a requirement for a threshold concentration of GATA-1 Is part of the mechanism that determines the final steps of erythroid maturation.
INTRODUCTION
Differentiation is a complex process which occurs through programmed changes in gene expression, controlled at several hierarchies. Expression of specific genes is regulated by numerous transcription activators through their binding to specific DNA motifs, creating a multitude of potential interactions. The mechanism by which particular interactions, leading to a specific differentiation route, are selected is still not understood.
Hematopoiesis, the continuous production of mature blood cells from pluripotent stem cells, has provided an attractive model for differentiation studies. Many of these studies have been performed on cell-lines, immortalized at various stages of hematopoietic differentiation. Those studies led to the identification of transcription factors playing crucial roles in different hematopoietic lineages, in particular the erythroid and lymphoid series. However, the multistage characteristics of the hematopoietic differentiation process requires that the molecular events be elucidated at each precise step. Primary cultures cover a longer span of the differentiation process and better represent the in vivo events than the available cell-lines, in which normal differentiation has been perturbed by immortalization and transformation.
We have recently developed an experimental system based on progenitors present in human peripheral blood, BFUe, cultured in two steps (1) . In the first step the BFUe proliferate and differentiate into the more mature progenitors, CFUe. In the second step, in response to Epo, the CFUe further proliferate and mature into hemoglobin-containing cells. These primary cultures provide sufficient amounts of differentiating erythroid cells for biochemical studies (2) . Our previous studies suggested that the patterns of human globin gene expression as well as the globin switch are recapitulated under these culture conditions. In the present project we used this experimental system to focus on the appearance of the erythroid specific transcription activator GATA-1.
GATA-1 (rev. in (3, 4) ) is a zinc finger protein (5, 6) , which functions as a major transcriptional regulator of erythroid differentiation (7, 8) . GATA-1 regulates several erythroid specific genes, such as globin (rev. in (9) ), EpoR (10, 11) and porphobilinogen deaminase (an enzyme in the heme biosynthetic pathway) (12) . Its core binding motif, with the consensus sequence (A/T)GATA(A/G), has been found in the promoter and enhancer regions of many erythroid-specific genes, including the regulatory region of GATA-1 itself (13 -15) . Studies on transcriptional activation by GATA-1 suggested important interactions with other nuclear proteins, in particular those that bind to CACCC and AP-l/NFE-2 elements (16, 17) .
• To whom correspondence should be addressed GATA-1 has been detected not only in erythroblasts, but also in megakaryocytes and mast cells (18) (19) (20) , in a number of non tumorigenic myeloid cell-lines (21) , and in multipotent hematopoietic cell-lines (22) . Recently, abundant expression of GATA-1 was also detected in mouse testis (23) . The presence of GATA-1 in different tissues and several hematopoietic lineages and at various time-windows raises the question of the precise role of GATA-1 in erythroid maturation.
Recently GATA-1 expression was followed during several steps of differentiation of early human hematopoietic progenitors grown in vitro (24) . Those studies revealed activation of GATA-1 with the onset of mitotic activity of stem/progenitor cells. GATA-1 expression continued in differentiating erythroid cells and was turned off in cells of the granulocyte-monocyte pathway. These findings demonstrated that the GATA-1 gene is first activated in a common progenitor and is then further regulated during lineage-specific differentiation (24) , as had been suggested by earlier studies using cell-lines (18, 21) .
In the present study we investigated the kinetics of GATA-1 (and the ubiquitous factors SP1 and OTF-1) during normal erythroid maturation. We found a dramatic increase in GATA-1 mRNA level and DNA-binding activity following the addition of Epo and immediately prior to globin gene expression. Concurrent with hemoglobinization, GATA-1 mRNA and binding activity decreased to very low levels. These findings demonstrate the specific role of GATA-1 in the context of erythroid differentiation. Furthermore, the results imply that a high level of GATA-1 activity is essential for globin gene expression, suggesting that a threshold requirement for GATA-1 is part of the mechanism that determines the final steps of erythroid maturation.
MATERIALS AND METHODS

Cells and cultures
Buffy coat fractions were derived from whole units (400 ml) of adult blood. Fresh blood samples were obtained from the Hadassah blood bank, with informed consent of voluntary donors. The liquid culture system was employed, as previously described in detail (25) . Total viable cells were counted with trypan blue and hemoglobin-containing cells with the benzidine peroxidase reaction (26) . Early non-hemoglobinized erythroid cells and non erythroid cells were determined morphologically following staining with May-Grunwald Giemsa.
Nuclear extracts and gel retardation assay Nuclear miniextracts and cytoplasmic RNA were prepared from a total of 2x 10 6 cells for each time-point (27). 5'-end labeled oligonucleotides were annealed with an excess of the complementary oligonucleotide (28) and repurified by polyacrylamide gel electrophoresis. In vitro binding reactions (28) were performed on equal amounts of nuclear proteins obtained from 1. Intensities of the shifted bands was determined by densitometric scanning of the autoradiograms, exposed without intensifying screens, using Microtec ScanMaker 600 ZS, analysed by NIH Image 1.41 program.
Oligonucleotides for the gel retardation assay GATA-1: derived from the promoter region of the mouse a-\ globin gene (29) Oligonucleotides for the GATA-1 mRNA analysis The PCR primers, 5' GCCCATCTCTACCAAGGCCT 3' and 5' AGAAGGACACCACCCCTCCT 3', are derived from the 3' end of the human GATA-1 mRNA, producing a 204 bp amplification product.
RNA analyses
Total RNA was harvested from 2-4X10 6 cells. In some experiments cytoplasmic RNA was harvested in parallel to the nuclear extracts (27) . In others, one half of each culture was harvested for RNA by acid guanidinium thiocyanate-phenolchloroform extraction (31) , and the other half for nuclear extracts. Both methods yielded similar results. To ensure that the RNA had not been degraded, samples were analysed by gel electrophoresis and ethidium bromide staining. Ribosomal RNA and tRNA appeared intact. Comparable amounts of ribosomal RNA, representing a comparable number of cells, were used for each analysis.
GATA-1 mRNA analysis was performed by the reverse transcriptase-polymerase chain reaction (RT-PCR). 150-300 ng of RNA were used in each RT reaction (Moloney murine leukemia virus RT, BRL) with oligo(dT) primer. One tenth of each RT product was amplified by PCR in a total reaction of 50 n\, in the presence of 5X10 6 cpm of an 32 P-labeled oligonucleotide primer. The amplification cycle was: denaturation at 92°C for 1.5 min, annealing at 60°C for 1 min, and extension at 72°C for 1 min, for 20 cycles. Aliquots of the reaction products (1/5 volume) were analyzed by electrophoresis in 8% native acrylamide gel and autoradiography. Quantitative determinations were performed as described for the gel retardation assays.
For (S-globin mRNA analysis cytoplasmic RNA was harvested in parallel to the nuclear extracts (27) . After denaturation with formaldehyde, RNA samples (3 ftg) were applied to a nitrocellulose membrane using a slot-blot apparatus. Hybridization to a 3' /3-globin RNA probe (2) was performed in 50% formamide, at 42°C.
RESULTS
A burst of GATA-1 activity follows the addition of Epo
Erythroid progenitors derived from peripheral blood of a normal adult were grown in the two-step culture. In the first phase mononuclear cells were cultured in liquid medium supplemented with conditioned medium containing hematopoietic growth factors, not including Epo. We have previously shown uiat during this stage (phase I) BFUe, originally present in peripheral blood, proliferated and differentiated into CFUe (1). Seven days later, the non adherent cells were washed and replated in medium containing Epo (phase II) (25) . At the first two days, the bulk of the cells were small, quiescent (as determined by flow cytometry, data not shown) lymphocytes, while 3-6% of the cells were immature myeloid cells and 5-7% of the cells were mature myeloid cells (neutrophils, monocytes/macrophages). Erythroid cells were first discernible on day 3. These were proerythroblasts, characterized as large, smoothly rounded cells, with a large nucleus and dark blue cytoplasm (1) and no detectable hemoglobin, as judged by benzidine staining. After day 3, as these cells rapidly proliferated, the relative number of the nonerythroid cells decreased. Megakaryocytes first appeared on day 7; their level never exceeded 1%. Cells were harvested at intervals, starting from day 0 (of phase H), when Epo was added. Nuclear proteins were extracted and GATA-1 level was analyzed by the gel retardation assay, using an end-labeled double stranded oligonucleotide containing the GATA-1 binding site. The autoradiogram of the band-shifting is shown in Fig. 1 . It can be seen that GATA-1 binding activity first appeared on day 3, increased until day 8-9 and then decreased.
Quantitation of the intensity of the shifted bands was performed by densitometric scanning of the autoradiogram shown in Fig. 1 . The results are summarized graphically in Fig. 2A There was no detectable GATA-1 binding activity before the addition of Epo. The level of GATA-1 reached its peak on day 8-9, when 50-60% of the erythroid cells became hemoglobinized. The rise in total GATA-1 activity in the culture is due to an increase in the level of GATA-1 per erythroid cell as well as the increase in the erythroid cell population. After day 8 -9, as the culture continues to differentiate and the population of erythroid cells continues to increase, the level of GATA-1 decreases dramatically. A significant level of GATA-1 activity is present on day 3, when the number of erythroid cells is still very low. Assuming that GATA-1 is exclusively present in the erythroid cells (see below), the GATA-1 level per cell at this stage is already very high. It reaches a peak on day 7, before the major rise in the number of hemoglobinized cells (Fig. 2A) .
Studies of primary cultures may be influenced by the genetic background of individual donors. Therefore, cultures obtained from 4 additional donors were analyzed in a similar fashion. The results were essentially reproducible for all the 5 cultures, although there were some minor variations in the kinetics of appearance of erythroid cells and in the percentage of hemoglobinized cells. A summary of the data for GATA-1 for all 5 cultures is presented in Fig. 2B . Importantly, all the cultures showed a dramatic rise in the level of GATA-1/erythroid cell between days 4 and 8.
The increase in GATA-1 activity precedes globin mRNA expression To investigate the temporal correlation between GATA-1 binding activity and globin mRNA expression, we analyzed one of the cultures for /3-globin RNA. Equal amounts of cytoplasmic RNA, harvested in parallel to the nuclear extracts, were hybridized to a /3-globin mRNA probe. The results (Fig. 3) show that the major elevation in |3-globin mRNA occurred on days 7-9 (closed triangles), immediately after the burst in GATA-1 activity (open squares) and before the rise in the number of hemoglobinized cells (closed circles). These results are consistent with our previous findings on globin mRNA synthesis, performed by RNase mapping analyses (2) . Thus the burst in GATA-1 activity precedes globin gene transcription in these differentiating cultures.
Biphasic pattern of SPl kinetics
For better understanding the process of erythroid differentiation and in order to compare between erythroid-specific and non specific transcription factors we analyzed the same nuclear extracts for the ubiquitous factor SPl. We utilized an oligonucleotide from a mutant 7-globin promoter (-198 HPFH Figure 5 . OTF-1 binding activity. Gel retardation analysis was performed on die same nuclear extracts shown in Fig. 1 , widi the oligonucleotide derived from die promoter of the human IgH gene. Epo was added at day 0. A. The arrow points to die OTF-1 shifted band. C-binding in die presence of 100 fold molar excess of unlabeled competitor oligonucleotide. B. Scanning of die autoradiogram. mutation), which was previously shown to be a strong binding site for SPl and for additional unidentified proteins (30) . A representative gel retardation assay is shown in Fig. 4A and is graphically summarized in Fig.4B . SPl binding activity was not detected in the quiescent cells on day 0, before the addition of Epo. The kinetics of the SPl binding activity of this culture and the other 4 cultures typically showed a trend towards a biphasic pattern with two peaks, the first on day 3-4 and the second on day 8-10. The second peak usually coincided with the GATA-1 peak, when the erythroid cells dominated the cultures. SPl activity decreased again when the erythroid cells continued to mature, on day 10-15.
Modulation of OTF-1 kinetics
The binding activity of the ubiquitous transcription factor OTF-1 is shown in Fig. 5A and is graphically summarized in Fig. 5B . The other 4 cultures were similarly analysed. In 2 of the 5 cultures, OTF-1 binding activity was already present on day 0. In general, OTF-1 activity fluctuated at a high level, without a consistent pattern. In 3 of the 5 cultures the OTF-1 level remained high until the last day, when GATA-1 and SPl levels were low.
Specificity of the burst in GATA-1
The high level of OTF-1 throughout most of the culture period, while the relative composition of erythroid and non erythroid cells was changing, supports the ubiquitous nature of this transactivator. We have therefore used it as an internal standard for evaluating the specificity of GATA-1 activity.
A significant level of OTF-1 is already seen on day 3, when GATA-1 activity first appears. The ratio of GATA-1/OTF-1, which is very low on day 3, rises dramatically in all 5 cultures (Fig. 6) , indicating that the sharp rise in GATA-1 is specific and not due to a general increase in transcriptional activators. 
GATA-1 activity was not observed in the absence of Epo
We further asked whether GATA-1 activity can be detected in the absence of Epo, either in the first, Epo independent phase of the culture, or in the second phase, in cells cultured without Epo. Nuclear extracts of 4 phase I cultures, harvested at several timepoints, had no detectable GATA-1 binding activity (not shown). The majority of the cells (about 90%) were lymphocytes, 3-6% were myeloblasts and myeloid precursors and additional 5% were mature myeloid cells. No megakaryocytes were visible.
At the end of the phase I, the cells were replated for phase II in the presence of conditioned medium, but without Epo. Again, GATA-1 activity was not observed in any of the 4 cultures (not shown). The cellular composition of the second phase Epo" cultures was similar to that of the first phase, except that megakaryocytes were also present (less than 1%). Control experiments (cells of the same culture plated in parallel in the presence of Epo) showed that all 4 cultures contained early erythroid progenitors, yielding 87-92% of hemoglobinized cells.
These Epo~, second phase cultures had both SP1 and OTF-1 binding activities (Fig. 7) . The SP1 level, appearing as a single faint band corresponding to the uppermost of the two SP1 shifted complexes, was visible only at days 7 tolO. For comparison, the level of SP1 in an Epo + culture at day 8 is shown in lane 9. On the other hand OTF-1 level was high and relatively constant, corroborating the ubiquitous nature of this factor.
Since the numbers of the various types of nonerythroid cells in cultures grown without Epo were similar to those of the cultures grown with Epo, and since the Epo" cultures did not have any GATA-1 activity, we concluded that in our experiments the GATA-1 activity detected in the Epo + cultures was contributed only by the erythroid cells, and not by other cells of the myeloid lineage present in the Epo + cultures.
Epo induces GATA-1 gene expression at the transcriptlonal level We proceeded to examine the level of GATA-1 mRNA using the RT-PCR method. As observed by others (24), a low level of GATA-1 mRNA was detected before the addition of Epo (Fig. 8A, day 0) . Several days after Epo was added GATA-1 mRNA showed a sharp increase, concurrent with the increase in GATA-1 binding activity (Fig 8B) . Both reached a peak on day 8, followed by a sharp decrease. These results were reproduced in two additional cultures. Linearity of the RT-PCR reaction within the range of 75-750 ng total cellular RNA has been demonstrated by using serial dilutions of K562 mRNA (Fig. 8C.D) . 
DISCUSSION
The present study demonstrates the utility of the erythroid liquid culture system in studying differentiation at the molecular level in a physiological meaningful context. Cultures derived from different individuals showed similar differentiation kinetics and provided evidence for reproducible changes in transcription factor levels (as seen in Fig. 2B and Fig. 6 ), in spite of genetic and physiological differences among individual blood donors. The data can be internally controlled and normalized using as a reference binding activities (e.g. OTF-1) which remain relatively stable. This system is presently being adapted to the analysis of neonatal cord blood cells, and this will open the way to studies on the hemoglobin switch.
The results show that in differentiating human erythroid cells the levels of GATA-1 mRNA and DNA-binding activity increase sharply after the addition of Epo. The concurrent rise in both mRNA and binding activity (Fig. 8B) suggests that translational regulation and protein activation do not play a significant role in ccmtrolling GATA-1 function during erythroid maturation. The increase in GAT A-1 binding activity after the addition of Epo is dramatic, in particular relative to the level of the ubiquitous factor OTF-1 (Fig. 6) . The major rise precedes the increase in the number of erythroid cells, implying a significant burst of GATA-1 activity in the proervthroblast.
Globin mRNA transcription immediately follows the burst in GATA-1 activity (Fig. 3) . This temporal correlation corroborates the major role of GATA-1 in globin gene expression and demonstrates the utility of this culture system for studying in vivo processes.
Later during the culture period, the total levels of GATA-1 mRNA and binding activity rapidly decline, even though the number of erythroid cells continues to increase. From the close correlation between their decline (Fig. 8B ) it appears that like other transcription factors, the GATA-1 protein is also unstable. The decrease in GATA-1 expression probably occurs only after sufficient levels of transcription of globin and other erythroidspecific genes have been achieved. The mechanism of turnoff of GATA-1 gene activity is as yet unknown.
Our assay did not detect any GATA-1 binding activity in the absence of Epo. This was expected, since proerythroblasts were not present under these conditions and the number of megakaryocytes was low (< 1 %). However, using the sensitive polymerase chain reaction, GATA-1 mRNA was observed before the addition of Epo (Fig. 8A ), as also shown by others (24) . Analyses of the kinetics of SP1 showed that its level fluctuated during the culture period, usually showing a peak coincident with the major rise in the number of erythroblasts, followed by a decrease in a late phase of the culture. This is in contrast to the results obtained with OTF-1, whose activity is relatively stable. We suggest that although SP1 is present in many cell types, its activity is modulated according to the proliferative state of the cells and the differentiation process. It has been shown that SP1 is present at significantly different levels in different cell-lines (22, 32) . The cultures grown in the absence of Epo had a much lower level of SP1 than those grown with Epo (Fig 7) , suggesting a specific role for SP1 in erythroid differentiation. SP1 binding motifs are typically seen in regulatory regions (locus control region-LCR, promoters and enhancers) of globin genes (33) as well as other erythroid genes, including porphobilinogen deaminase (12), EpoR (11), glycophorin B (34) and GATA-1 (13, 14, 35) . Mutations of SP1 binding sites affect the expression of these genes in transfection experiments (13, 14) , and appear to be the underlying defect in a type of human /3-thalassemia (36) . Intriguingly, SP1 and GATA-1 binding motifs are usually closely associated (33) . Furthermore, it has been suggested that the levels of GATA-1 and SP1 play an important role in the mechanism of globin switch in the chicken (37) . It may therefore be of significance that the second peak of SP1 activity is coincident with the appearance of large numbers of erythroid cells and the peak of (total) GATA-1 activity.
Based on the results presented here and those of others, we have formulated a model for the role of GATA-1 in erythroid maturation (Fig. 9) .
GATA-1 expression is induced by Epo, a primary regulator of erythroid maturation whose biological effect is mediated via a cell surface receptor, EpoR (38) . The EpoR gene is expressed at low levels before either hematopoietic or erythroid commitments has occurred (22) . Commitment to macrophage or lymphocytic lineages results in the turn-off of EpoR gene expression, whereas commitment to the erythroid lineage is either concurrent with or followed by a dramatic increase in EpoR gene expression (22) . It has been suggested that GATA-1 plays a regulatory role in the erythroid specific control of EpoR gene expression (10, 22, 38) . Furthermore, although the EpoR gene may be expressed in early myeloid cells expressing GATA-1, functional receptors were found only in cells committed to the erythroid and megakaryocytic lineages (39, 40) .
GATA-1 binding motifs are present in the promoter region of the human GATA-1 gene itself (15, 35) , implying that the gene is positively autoregulated, as has been shown for the mouse (8, 14, 35) and chicken (13) . This may be part of the mechanism underlying the burst of GATA-1 activity observed in our experiments. In positively autoregulated gene expression the level of gene product determines the rate of transcription, which inturn affects protein level. One would therefore predict that autoregulation would result in a parallel sharp increase in both mRNA and protein, as indeed observed in our experiments. It may be of note that in megakaryocytic differentiation GATA-1 is probably not autoregulated (41) .
Amplification of a primary differentiation signal may be a general mechanism underlying the determination of the fate of the differentiating cell. Amplification may allow a transcriptional activator to reach a threshold level, required for the activation of specific target genes. The threshold phenomenon facilitates the conversion of a shallow concentration gradient of a signal, such as transcriptional activator, into a sharp off/on decision in the transcription of a target gene. A classical example is the generation of asymmetry along the anterior-posterior axis during early Drosophila embryogenesis (42) . The shallow gradient of the maternally derived bicoid (bed) protein is converted into distinct spatial domains in the embryo through a sharp increase in the transcriptional activation of the zygotic segmentation hunchback (hb) gene. Furthermore, a single transcriptional activator may activate in a sequential order several target genes, responding to different threshold concentrations (42, 43) . The threshold phenomenon may be mechanistically inherent to the chromatin nature of the eukaryotic transcriptional template, as recently demonstrated by elegant in vitro transcription studies (44) .
As explained above, both GATA-1 and EpoR, key proteins in erythroid maturation, are also present at low levels in early pluripotent myeloid progenitors. Our model (Fig. 9) suggests that the threshold effect is part of the mechanism which determines erythroid commitment. Our studies demonstrate that Epo induces GATA-1 expression in the differentiating CFUe, by a mechanism which is not fully understood, probably via activation of phospholipases A2 and C (45) . Additional regulatory factors may also be involved. We propose that in response to the Epo-induced signal GATA-1 reaches a first threshold level, allowing transactivation of the EpoR gene (Fig. 9) . This leads to an increase in the number of Epo receptors on the cell surface, initiating an amplification loop which, together with GATA-1 autoregulation, accounts for the steep rise in GATA-1 mRNA and binding activity observed in our experiments. The level of GATA-1 then reaches a second threshold, required for transactivation of genes of hemoglobin biosynthesis (globin and porphobilinogen deaminase), leading to hemoglobinization and erythroid maturation.
